Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
38.63
-0.27 (-0.69%)
Dec 20, 2024, 4:00 PM EST - Market closed
Xenon Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$56.67
Upside
+46.70%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $53 | Strong Buy | Reiterates | $53 | +37.20% | Dec 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $53 | Strong Buy | Reiterates | $53 | +37.20% | Nov 13, 2024 |
Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +55.32% | Nov 13, 2024 |
Raymond James | Raymond James | Buy Initiates $50 | Buy | Initiates | $50 | +29.43% | Oct 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $53 | Strong Buy | Initiates | $53 | +37.20% | Oct 1, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +42.38% | Sep 3, 2024 |
Needham | Needham | Strong Buy Maintains $62 → $60 | Strong Buy | Maintains | $62 → $60 | +55.32% | Aug 12, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +68.26% | Aug 9, 2024 |
Wedbush | Wedbush | Buy Maintains $50 → $49 | Buy | Maintains | $50 → $49 | +26.84% | Aug 9, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +42.38% | Jun 18, 2024 |
Needham | Needham | Strong Buy Maintains $62 | Strong Buy | Maintains | $62 | +60.50% | May 10, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $62 → $60 | Strong Buy | Maintains | $62 → $60 | +55.32% | May 10, 2024 |
Wedbush | Wedbush | Buy Maintains $51 → $50 | Buy | Maintains | $51 → $50 | +29.43% | May 10, 2024 |
Needham | Needham | Strong Buy Reiterates $62 | Strong Buy | Reiterates | $62 | +60.50% | Apr 12, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +68.26% | Apr 10, 2024 |
RBC Capital | RBC Capital | Buy Maintains $56 → $55 | Buy | Maintains | $56 → $55 | +42.38% | Mar 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.